ATTR-CM Hospitalization Consequences | Attruby® (acoramidis)
ATTR-CM Hospitalization Consequences | Attruby® (acoram…
8 months ago
linkedin.com
The News That Could Stoke BridgeBio, Up 80% This Year
The News That Could Stoke BridgeBio, Up 80% This Year
7 months ago
investors.com
Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients
Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), a…
Nov 22, 2024
marketscreener.com
Learn more about how Attruby can help adults with ATTR-cardiac amyloidosis. Please see Important Safety Information at Attruby.com/#ISI for Attruby® (acoramidis) and Full Prescribing Information and Patient Information at Attruby.com/PI. | Morgan Freeman
2:09
Learn more about how Attruby can help adults with ATTR-cardiac am…
23.4K views7 months ago
FacebookMorgan Freeman
Acoramidis: A Potential Breakthrough Treatment for Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) | Cardiology
Acoramidis: A Potential Breakthrough Treatment for Trans…
Jul 18, 2023
labroots.com
BridgeBio Pharma, Inc.: BEYONTTRA (acoramidis), the First Near Complete TTR Stabilizer (=90%), Approved by the European Commission to Treat ATTR-CM
BridgeBio Pharma, Inc.: BEYONTTRA (acoramidis), the Fir…
6 months ago
finanznachrichten.de
Impact of Attruby on serum TTR levels
Impact of Attruby on serum TTR levels
5 months ago
linkedin.com
0:59
Please see Important Safety Information at Attruby.com/#ISI fo…
57.5K views1 year ago
FacebookMorgan Freeman
0:40
New Breakthrough in Heart Failure Treatment: Acoramidis for ATTR-CM
1.9K viewsDec 5, 2024
YouTubeMUSC Health
BridgeBio Pharma, Inc.: Acoramidis Shows Statistically Significant Im…
Mar 31, 2025
finanznachrichten.de
BridgeBio Pharma reports Attruby product revenue $146 mln in Q4
4 months ago
marketscreener.com
BridgeBio Pharma: ATTRibute-CM Study Fails To Meet Primary Endp…
Dec 27, 2021
nasdaq.com
Attruby TV Spot, 'A Diagnosis Doesn't Define You' Featuring Mor…
Apr 1, 2025
iSpot.tv
Morgan Freeman on Instagram: "Please see Important Safety Infor…
95.3K views1 year ago
Instagrammorganfreeman
BridgeBio Pharma, Inc.: BridgeBio Announces Commercial Progress…
Jan 13, 2025
finanznachrichten.de
LLNL and BridgeBio announce trials for supercomputing-discovered ca…
Jun 27, 2024
llnl.gov
Early Diagnosis of Transthyretin Amyloid Cardiomyopathy
9 months ago
medscape.com
4:51
ATTRUBY - FDA NDA approval - 2024-11-22
222 viewsDec 11, 2024
YouTubeInside Drug Discovery
1:01
Learn more about how Attruby can help adults with ATTR-cardiac am…
112 views6 months ago
YouTubeMorgan Freeman
BridgeBio's Most 'Hotly Debated' Drug Scores Big In Phase 3
3 months ago
investors.com
We’re honored to be recognized at this year’s Med Ad News Manny A…
1 month ago
linkedin.com
19:42
罕見疾病新星爆發！BridgeBio (BBIO) 三大新藥報捷，單挑輝瑞巨頭，20…
23 views2 months ago
YouTube來聽美股吧
BridgeBio LLC
Nov 30, 2017
biospace.com
1:49
BridgeBio Raised $135M to Fund 10 Drugs at Once—Here’s How
146 views9 months ago
YouTubeMelissa Bime
18:35
Why BridgeBio Stopped Galactosemia Gene Therapy
116 views3 months ago
YouTubeThe Galactosemia Podcast
7:33
罕見疾病新星爆發！BridgeBio (BBIO) 三大新藥報捷，單挑輝瑞巨頭，20…
45 views2 months ago
YouTube來聽美股吧
1:52
How BridgeBio Transformed Compliance With Egnyte’s GxP Co…
124 viewsApr 30, 2025
YouTubeEgnyte
2:41
How the Attruby Digital Companion on Medisafe Can Help You Stay o…
217 views8 months ago
YouTubeAttruby® (acoramidis)
1:15
How to Invest in Bridgebio Pharma Inc (BBIO) Step by Step
1 views1 month ago
YouTubeInvesting Step by Step
This Biotech Is On A Triple-Digit Run, And Shows No Signs Of Slo…
5 months ago
investors.com
See more videos
Static thumbnail place holder